Last reviewed · How we verify
Adjustment of Antiplatelet Drugs
Adjustment of Antiplatelet Drugs is a Small molecule drug developed by Beijing Tiantan Hospital. It is currently in Phase 1 development.
At a glance
| Generic name | Adjustment of Antiplatelet Drugs |
|---|---|
| Sponsor | Beijing Tiantan Hospital |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- STrategies for Antithrombotic tReatment Following Transcatheter Edge-to-Edge Repair in Patients With an Indication for Oral Anticoagulant (PHASE4)
- Anticoagulation Therapy in Non-device-related Intra-cardiac Thrombus (PHASE3)
- Stent Implantation Versus Medical Therapy for Idiopathic IntracraniaL Hypertension (SIMPLE) (PHASE3)
- Colchicine Treatment for Non-Flow-Limiting Coronary Plaque by Coronary CTA: A Randomized Controlled Trial (PHASE4)
- Chinese Herbal Therapy (Qiqi Shengmai Formula) for Moyamoya Vasculopathy: The CHIMES Trial (PHASE1)
- Effect of Oral Antiplatelet or Anticoagulant Drugs on Postoperative Bleeding Risk and Venous Closure Rate in Patients With Lower Extremity Varicose Veins After Radiofrequency Ablation
- Syntrillo Telehealth Stroke Risk Reduction Study (NA)
- Traditional Chinese Medicine Intervention for Ischemic Cerebrovascular Disease and Diabetes Mellitus: An Efficacy Comparative Study (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Adjustment of Antiplatelet Drugs CI brief — competitive landscape report
- Adjustment of Antiplatelet Drugs updates RSS · CI watch RSS
- Beijing Tiantan Hospital portfolio CI
Frequently asked questions about Adjustment of Antiplatelet Drugs
What is Adjustment of Antiplatelet Drugs?
Adjustment of Antiplatelet Drugs is a Small molecule drug developed by Beijing Tiantan Hospital.
Who makes Adjustment of Antiplatelet Drugs?
Adjustment of Antiplatelet Drugs is developed by Beijing Tiantan Hospital (see full Beijing Tiantan Hospital pipeline at /company/beijing-tiantan-hospital).
What development phase is Adjustment of Antiplatelet Drugs in?
Adjustment of Antiplatelet Drugs is in Phase 1.